BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21151169)

  • 1. Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy.
    Li LY; Dai HY; Yeh FL; Kan SF; Lang J; Hsu JL; Jeng LB; Chen YH; Sher YP; Lin WC; Hung MC
    Oncogene; 2011 Apr; 30(15):1773-83. PubMed ID: 21151169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
    Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
    Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
    Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice.
    Yang YJ; Chen DZ; Li LX; Sheng QS; Jin ZK; Zhao DF
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):174-8. PubMed ID: 19357032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
    Hirano T; Kaneko S; Kaneda Y; Saito I; Tamaoki T; Furuyama J; Tamaoki T; Kobayashi K; Ueki T; Fujimoto J
    Gene Ther; 2001 Jan; 8(1):80-3. PubMed ID: 11402306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
    Xie X; Xia W; Li Z; Kuo HP; Liu Y; Li Z; Ding Q; Zhang S; Spohn B; Yang Y; Wei Y; Lang JY; Evans DB; Chiao PJ; Abbruzzese JL; Hung MC
    Cancer Cell; 2007 Jul; 12(1):52-65. PubMed ID: 17613436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
    Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
    Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
    Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.
    Dai HY; Chen HY; Lai WC; Hung MC; Li LY
    Oncotarget; 2015 Sep; 6(27):23807-19. PubMed ID: 26247632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice.
    Ma SH; Chen GG; Yip J; Lai PB
    Gene Ther; 2010 Jul; 17(7):905-12. PubMed ID: 20336154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.